Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry
Circulation · 22.10.2024 · 150 (17) · 1377-1390
DOI: 10.1161/circulationaha.124.069378 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation, erschienen am 22.10.2024. Verfasst von Niccolò Maurizi und 28 weiteren Autor:innen. Beteiligte Einrichtung: Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy (N.M., C.F., I.O.). Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Registries. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Wellcome Trust.
Abstract (Originalsprache)
BACKGROUND: Septal reduction therapy (SRT) provides substantial symptomatic improvement in patients with obstructive hypertrophic cardiomyopathy (HCM). However, long-term disease course after SRT and predictors of adverse outcomes have not been systematically examined. METHODS: Data from 13 high clinical volume HCM centers from the international SHARE (Sarcomeric Human Cardiomyopathy Registry) were analyzed. Patients were followed from the time of SRT until last follow-up or occurrence of heart failure (HF) composite outcome (cardiac transplantation, implantation of a left ventricular assist device, left ventricular ejection fraction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy (N.M., C.F., I.O.).
- Service of Cardiology, University Hospital of Lausanne, Switzerland (N.M., P.A., I.S.).
- Penn Center for Inherited Cardiovascular Disease, Hospital of the University of Pennsylvania and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia (A.O., A.S.N., A.D.F.A., N.R., S.M.D.).
- Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (N.L., C.Y.H.).
- Departments of Internal Medicine (S.S., A.S.H.), University of Michigan, Ann Arbor.
- Pediatrics (M.W.R.), University of Michigan, Ann Arbor.
ORCID-Profile: Niccolò Maurizi, Panagiotis Antiochos, Anjali Owens, Neal Lakdawala, Sara Saberi, Carlo Fumagalli, Kimberly Y Lin, Ashwin S Nathan, Nosheen Reza, John C Stendahl, Dominic Abrams, Christopher Semsarian, Brian Clagget, Rachel Lampert, Matthew Wheeler, Victoria N Parikh, Euan Ashley, Michelle Michels, Joseph Rossano, Thomas D Ryan, Jodie Ingles, Sharlene M Day, Iacopo Olivotto
Förderung
- NHLBI NIH HHS
- Wellcome Trust
Zitieren
APA
Maurizi, N., Antiochos, P., Owens, A., Lakdawala, N., Saberi, S., Russell, M. W., Fumagalli, C., Skalidis, I., Lin, K. Y., Nathan, A. S., De Feria Alsina, A., Reza, N., Stendahl, J. C., Abrams, D., Semsarian, C., Clagget, B., Lampert, R., Wheeler, M., Parikh, V. N., …, & Olivotto, I. (2024). Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry. Circulation, 150(17), 1377-1390. https://doi.org/10.1161/circulationaha.124.069378
Vancouver
Maurizi N, Antiochos P, Owens A, Lakdawala N, Saberi S, Russell MW, et al. Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry. Circulation. 2024;150(17):1377-1390. doi:10.1161/circulationaha.124.069378
BibTeX
@article{Maurizi2024,
author = {Maurizi, Niccolò and Antiochos, Panagiotis and Owens, Anjali and Lakdawala, Neal and Saberi, Sara and Russell, Mark W and Fumagalli, Carlo and Skalidis, Ioannis and Lin, Kimberly Y and Nathan, Ashwin S and De Feria Alsina, Alejandro and Reza, Nosheen and Stendahl, John C and Abrams, Dominic and Semsarian, Christopher and Clagget, Brian and Lampert, Rachel and Wheeler, Matthew and Parikh, Victoria N and Ashley, Euan and Michels, Michelle and Rossano, Joseph and Ryan, Thomas D and Ingles, Jodie and Ware, James and Ho, Carolyn Y and Helms, Adam S and Day, Sharlene M and Olivotto, Iacopo},
title = {Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry},
journal = {Circulation},
year = {2024},
volume = {150},
number = {17},
pages = {1377--1390},
doi = {10.1161/circulationaha.124.069378}
}
EUVIMED